Arun Sawhney, the managing director of Ranbaxy Labs Ltd, doesn?t live in denial, nor does he postpone the admission of…

Making sense of time-space continuum and trying to unearth patterns in it has been one of the oldest obsessions of…

Pharma stocks, which are already much celebrated on the bourses for being recession-proof, also proved to be policy shock-proof in…

Rajesh Jain, joint managing director of Panacea Biotec, the second-largest vaccine maker in the country, talks about the company?s plans…

In her early days, when Ameera Shah, managing director of Metropolis Healthcare, entered a client?s office with her sales manager,…

The new pharma pricing policy is likely to be notified on Monday or sometime early this week. The policy got…

Life expectancy at 65 years is the lowest in India, compared to 73 in Brazil, 74 in China and 68…

The Indian arm of the $800-million Omron Healthcare, which has a 60% marketshare in BP monitors here, plans to increase…

Substituting the weighted average pricing formula with the simple average formula in the pharma pricing policy may increase the impact…

Should the cost-based formula for fixing prices be replaced by a market-based one?

A recent health ministry move to bar state drug regulators from granting manufacturing licences on brand names may be relaxed…

The finance ministry’s objections to the proposed market-based drug pricing policy, which forced the Cabinet to defer a decision on…

The laxness in branding medicines, a common practice for long but with serious implications for public health besides being an…

The Centre is set to establish a drug recall system through which it can order pharma firms to withdraw defective…